TAK-756
TAK-756 is a TAK1 inhibitor with good selectivity for IRAK1/4 and excellent intra-articular pharmacokinetic properties. TAK1 is a potential molecular target for osteoarthritis (OA) with complementary anti-catabolic and anti-inflammatory effects[1].
Product Specifications
UNSPSC
12352005
Target
MAP3K
Related Pathways
MAPK/ERK Pathway
Field of Research
Inflammation/Immunology
Smiles
O=C(C1=CC(C2=NOC(C3=CC(CN4C)=C(C=C3O[C@@H]5CC[C@@H](CC5)O)C4=O)=C2)=CC=C1)N
Molecular Formula
C25H25N3O5
Molecular Weight
447.48
References & Citations
[1]Langlois JB, et al. Identification of TAK-756, A Potent TAK1 Inhibitor for the Treatment of Osteoarthritis through Intra-Articular Administration. J Med Chem. 2024 Dec 12;67 (23) :21163-21185.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
PKSH031973 100 µg
Recombinant Human Respiratory Syncytial Virus (RSV) (A, rsb1734) Glycoprotein G/RSV-G Protein (93% Homology) (His Tag)
Sign In for Pricing
View Details 
LY400010 100 µg
Apolipoprotein CIII (APOC3) (NM_000040) Human Over-expression Lysate
Sign In for Pricing
View Details 
